Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma

Auris Nasus Larynx

Volumn 30, Issue 4, 2003, Pages 403-412

  Satake, Kenichi ^a   Takagi, Emi ^a   Ishii, Akiko ^a   Kato, Yasumasa ^a,b   Imagawa, Yukari ^a   Kimura, Yuu ^a   Tsukuda, Mamoru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

All trans Retinoic acid; Calcitriol; Head and neck squamous cell carcinoma; OCT; TAC 101

Indexed keywords

22 OXACALCITRIOL; 4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDO]BENZOIC ACID; ANGIOGENIC FACTOR; BENZOIC ACID DERIVATIVE; CALCITRIOL; CISPLATIN; FLUOROURACIL; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOL; SURVIVIN; TAC 101; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN RECEPTOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MOUTH CARCINOMA; NICK END LABELING; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR DIFFERENTIATION; UPREGULATION;

EID: 0345377531     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(03)00091-9     Document Type: Article

References (43)

1. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 15:1978;393-403.
2. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936-2940.
3. Petkovich M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;444-450.
4. Giguere V., Ong E.S., Segui P., Evans R.M. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
5. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3294-3298.
6. Sacks P.G., Oke V., Amos B., Vasey T., Lotan R. Modulation of growth, differentiation and glycoprotein synthesis by beta-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer. 44:1989;926-933.
7. Zou C.P., Clifford J.L., Xu X.C., Sacks P.G., Chambon P., Hong W.K., et al. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res. 54:1994;5479-5487.
8. Jetten A.M., Kim J.S., Sacks P.G., Rearick J.I., Lotan D., Hong W.K., et al. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid. Int. J. Cancer. 45:1990;195-202.
9. Lippman S.M., Benner S.E., Hong W.K. Cancer chemoprevention. J. Clin. Oncol. 12:1994;851-873.
10. Oridate N., Lotan D., Xu X.C., Hong W.K., Lotan R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl) retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 2:1996;855-863.
11. Diaz G.D., Paraskeva C., Thomas M.G., Binderup L., Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 60:2000;2304-2312.
12. Makin G., Hickman J.A. Apoptosis and cancer chemotherapy. Cell Tissue Res. 301:2000;143-152.
13. Baker S.J., Fearon E.R., Nigro J.M., Hamilton S.R., Preisinger A.C., Jessup J.M., et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:1989;217-221.
14. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
15. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
16. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366:1993;707-710.
17. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
18. Reed J.C., Miyashita T., Takayama S., Wang H.G., Sato T., Krajewski S., et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell Biochem. 60:1996;23-32.
19. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1998;882-883.
20. Light B.W., Yu W.D., McElwain M.C., Russell D.M., Trump D.L., Johnson C.S. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res. 57:1997;3759-3764.
21. Murakami K., Sakukawa R., Sano M., Hashimoto A., Shibata J., Yamada Y., et al. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Clin. Cancer Res. 5:1999;2304-2310.
22. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
23. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841-844.
24. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol. Int. 19:1995;431-444.
25. Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
26. Sakukawa R., Murakami K., Ikeda T., Yamada Y., Saiki I. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells. Oncol. Res. 10:1998;287-293.
27. Fujimoto K., Hosotani R., Doi R., Wada M., Lee J.U., Koshiba T., et al. Induction of cell-cycle arrest and apoptosis by a novel retinobenzoic-acid derivative, TAC-101, in human pancreatic-cancer cells. Int. J Cancer. 81:1999;637-644.
28. Endo K., Ichikawa F., Uchiyama Y., Katsumata K., Ohkawa H., Kumaki K., et al. Evidence for the uptake of a vitamin D analogue (OCT) by a human carcinoma and its effect of suppressing the transcription of parathyroid hormone-related peptide gene in vivo. J. Biol. Chem. 269:1994;32693-32699.
29. Eagle H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc. Soc. Exp. Biol. Med. 89:1955;362-364.
30. Xu X.C., Liu X., Tahara E., Lippman S.M., Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 59:1999;2477-2483.
31. Xu X.C., Ro J.Y., Lee J.S., Shin D.M., Hong W.K., Lotan R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 54:1994;3580-3587.
32. Castillo L., Milano G., Santini J., Demard F., Pierrefite V. Analysis of retinoic acid receptor beta expression in normal and malignant laryngeal mucosa by a sensitive and routine applicable reverse transcription-polymerase chain reaction enzyme-linked immunosorbent assay method. Clin. Cancer Res. 3:1997;2137-2142.
33. Crowe D.L. Retinoic acid receptor beta induces terminal differentiation of squamous cell carcinoma lines in the absence of cyclin-dependent kinase inhibitor expression. Cancer Res. 58:1998;142-148.
34. Wan H., Oridate N., Lotan D., Hong W.K., Lotan R. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. Cancer Res. 59:1999;3518-3526.
35. Zou C.P., Hong W.K., Lotan R. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Differentiation. 64:1999;123-132.
36. Virmani A.K., Rathi A., Zochbauer-Muller S., Sacchi N., Fukuyama Y., Bryant D., et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J. Natl. Cancer Inst. 92:2000;1303-1307.
37. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 40:2001;1117-1123.
38. Donaldson K.L., Goolsby G.L., Wahl A.F. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer. 57:1994;847-855.
39. Chen Z., Malhotra P.S., Thomas G.R., Ondrey F.G., Duffey D.C., Smith C.W., et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin. Cancer Res. 5:1999;1369-1379.
40. Eisma R.J., Spiro J.D., Kreutzer D.L. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope. 109:1999;687-693.
41. Sauter E.R., Nesbit M., Watson J.C., Klein-Szanto A., Litwin S., Herlyn M. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 5:1999;775-782.
42. Salven P., Heikkila P., Anttonen A., Kajanti M., Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod. Pathol. 10:1997;1128-1133.
43. Arnold A. Moving promising research findings to the clinic: methodological issues in the design and conduct of clinical trials of retinoids. Int. J. Cancer. 70:1997;467-469.